VIAN Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1M

  • Investors
  • 7

VIAN Therapeutics General Information

Description

Developer of a first-in-class topical therapy designed to treat retinal and ocular vascular diseases by targeting pathological angiogenesis and vascular dysfunction. The company offers non-invasive eye drops with targeted tissue penetration, enabling ophthalmology patients and clinical specialists to manage vision-threatening conditions without intraocular injections, thereby improving patient compliance and clinical outcomes.

Contact Information

Website
www.viantx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • San Francisco, CA
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • San Francisco, CA
  • United States

VIAN Therapeutics Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VIAN Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 24-Nov-2024 $1M Completed Pre-Clinical Trials
2. Accelerator/Incubator 25-Jun-2024 Completed Startup
1. Seed Round 01-Jun-2023 $280K $280K Completed Startup
To view VIAN Therapeutics’s complete valuation and funding history, request access »

VIAN Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view VIAN Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

VIAN Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a first-in-class topical therapy designed to treat retinal and ocular vascular diseases by targeting pathol
Biotechnology
San Francisco, CA
1 As of 2024

Springfield, IL
 

Ann Arbor, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

VIAN Therapeutics Competitors (8)

One of VIAN Therapeutics’s 8 competitors is RevOpsis Therapeutics, a Venture Capital-Backed company based in Springfield, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RevOpsis Therapeutics Venture Capital-Backed Springfield, IL
ONL Therapeutics Venture Capital-Backed Ann Arbor, MI
Allegro Ophthalmics Venture Capital-Backed San Juan Capistrano, CA
EOM Pharmaceuticals Holdings Corporation Montvale, NJ
Galimedix Therapeutics Venture Capital-Backed Kensington, MD
You’re viewing 5 of 8 competitors. Get the full list »

VIAN Therapeutics Patents

VIAN Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026174101-A1 Cyclic peptides with anti-angiogenic activity and methods of use Pending 12-Feb-2025

VIAN Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VIAN Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sand Hill Angels Angel Group Minority
Angel (individual) Minority
California Life Sciences Accelerator/Incubator
IndieBio Accelerator/Incubator Minority
SeedFolio Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

VIAN Therapeutics FAQs

  • When was VIAN Therapeutics founded?

    VIAN Therapeutics was founded in 2023.

  • Where is VIAN Therapeutics headquartered?

    VIAN Therapeutics is headquartered in San Francisco, CA.

  • What is the size of VIAN Therapeutics?

    VIAN Therapeutics has 1 total employees.

  • What industry is VIAN Therapeutics in?

    VIAN Therapeutics’s primary industry is Biotechnology.

  • Is VIAN Therapeutics a private or public company?

    VIAN Therapeutics is a Private company.

  • What is the current valuation of VIAN Therapeutics?

    The current valuation of VIAN Therapeutics is .

  • What is VIAN Therapeutics’s current revenue?

    The current revenue for VIAN Therapeutics is .

  • How much funding has VIAN Therapeutics raised over time?

    VIAN Therapeutics has raised $1.28M.

  • Who are VIAN Therapeutics’s investors?

    Sand Hill Angels, , California Life Sciences, IndieBio, and SeedFolio are 5 of 7 investors who have invested in VIAN Therapeutics.

  • Who are VIAN Therapeutics’s competitors?

    RevOpsis Therapeutics, ONL Therapeutics, Allegro Ophthalmics, EOM Pharmaceuticals Holdings, and Galimedix Therapeutics are some of the 8 competitors of VIAN Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process